Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1472-6823
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Plasminogen activator inhibitor-1 concentrations and bone mineral density in postmenopausal women with type 2 diabetes mellitus ; volume:16 ; number:1 ; day:3 ; month:3 ; year:2016 ; pages:1-7 ; date:12.2016
BMC endocrine disorders ; 16, Heft 1 (3.3.2016), 1-7, 12.2016
- Urheber
-
Canecki-Varžić, Silvija
- Beteiligte Personen und Organisationen
-
Prpić-Križevac, Ivana
Bilić-Ćurčić, Ines
SpringerLink (Online service)
- DOI
-
10.1186/s12902-016-0094-x
- URN
-
urn:nbn:de:1111-2016031111315
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Canecki-Varžić, Silvija
- Prpić-Križevac, Ivana
- Bilić-Ćurčić, Ines
- SpringerLink (Online service)
Ähnliche Objekte (12)
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator
Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers
Local Cerebral Recombinant Tissue Plasminogen Activator Concentrations During Acute Stroke
Soluble urokinase plasminogen activator receptor (supar) concentrations are elevated in patients with neuroendocrine malignancies
Die Bedeutung der Plasminogenaktivatoren tissue-type-plasminogen activator und urokinase-type plasminogen activator für den Ischämie-Reperfusionsschaden
Bone Marrow Plasminogen Activator in Malignant Disease
Tissue Plasminogen Activator Induced Delayed Edema in Experimental Porcine Intracranial Hemorrhage: Reduction with Plasminogen Activator Inhibitor-1 Administration
Relationship between serum and tear levels of tissue plasminogen activator and plasminogen activator inhibitor-1 in diabetic retinopathy
Urokinase-type plasminogen activator receptor in vascular calcification
Influence of delivery on plasminogen activator inhibitor activity
Plasminogen Activator Release by Oral Contraceptives and Exercise
Isolation and Properties of Human Vascular Plasminogen Activator
Purification and Some Properties of Tissue Plasminogen Activator